AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 147 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,142,287 | +12.4% | 46,153 | +28.6% | 0.00% | 0.0% |
Q2 2023 | $1,016,461 | +78.5% | 35,892 | +42.1% | 0.00% | – |
Q1 2023 | $569,590 | -1.3% | 25,259 | +23.0% | 0.00% | – |
Q4 2022 | $576,847 | +137.4% | 20,543 | +139.1% | 0.00% | – |
Q3 2022 | $243,000 | -83.9% | 8,592 | -81.5% | 0.00% | -100.0% |
Q3 2019 | $1,506,000 | -74.7% | 46,472 | -61.1% | 0.00% | -66.7% |
Q2 2019 | $5,962,000 | -20.7% | 119,526 | +7.2% | 0.01% | -25.0% |
Q1 2019 | $7,521,000 | +67.5% | 111,526 | +14.5% | 0.01% | +60.0% |
Q4 2018 | $4,490,000 | -17.0% | 97,366 | +16.9% | 0.01% | -16.7% |
Q4 2015 | $5,409,000 | -56.0% | 83,316 | -52.2% | 0.01% | -60.0% |
Q3 2015 | $12,303,000 | -36.5% | 174,286 | -0.0% | 0.02% | -31.8% |
Q2 2015 | $19,371,000 | +1909.4% | 174,296 | +1605.1% | 0.02% | +2100.0% |
Q1 2015 | $964,000 | -16.4% | 10,222 | -0.7% | 0.00% | 0.0% |
Q4 2014 | $1,153,000 | +100.9% | 10,293 | +10.1% | 0.00% | 0.0% |
Q3 2014 | $574,000 | – | 9,351 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |